The consultation phase represents a critical decision point in your breast augmentation journey. The questions you ask during this appointment establish.
Content is educational and planning-oriented. It does not replace diagnosis, treatment, or personalized medical advice from a licensed healthcare professional. Outcomes vary by individual case.
Verify ABPS certification specifically—not just 'board certified'—as the gold standard credential for breast augmentation surgeons.
Request and review the FDA-mandated patient decision checklist, which covers BIA-ALCL risk, systemic symptoms, and rupture screening.
Confirm facility accreditation (AAAASF, AAAHC, or JCAHO) and ask about your surgeon's annual procedure volume and complication rates.
Ask about MRI screening schedules for silicone implants—FDA recommends starting 5-6 years post-implantation.
Document all answers and request written materials; the consultation sets the foundation for informed consent.
Educational information only
This content is general education and does not replace evaluation by a licensed clinician. If you have symptoms, complications, or urgent concerns, seek in-person medical care.
Why Your Consultation Questions Matter
The consultation phase represents a critical decision point in your breast augmentation journey. The questions you ask during this appointment establish the foundation for informed consent and help you assess whether a particular surgeon and facility align with your expectations for safe, quality care.
The American Society of Plastic Surgeons emphasizes that patients should approach consultations as a two-way evaluation—you are assessing the provider just as they are assessing your candidacy for surgery [S4]. This means coming prepared with thoughtful questions reflects engagement in your own safety and outcome optimization.
Since 2019, the U.S. Food and Drug Administration has required manufacturers to provide patient decision checklists that must be reviewed and signed by both patient and surgeon before breast implant procedures [S2]. These federally mandated checklists cover essential topics including boxed warnings, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) risk, systemic symptoms, rupture screening recommendations, and implant registration requirements [S2]. Understanding that these checklists represent minimum disclosure standards can help you recognize the importance of asking additional questions beyond what is explicitly required [S3].
For patients considering procedures in Istanbul, the same principles of credential verification, facility accreditation assessment, and thorough risk discussion apply regardless of geographic location. Your active participation in the consultation through informed questioning helps ensure that the provider meets standards consistent with international best practices.
Surgeon Credentials and Training
Board Certification Verification
Board certification serves as the primary credentialing benchmark for plastic surgeons, but not all board certifications carry the same meaning. The American Board of Plastic Surgery (ABPS) represents the gold standard certification for breast augmentation surgeons in the United States and is recognized by the American Board of Medical Specialties (ABMS) [S1].
When verifying credentials, consider asking these specific questions:
"Are you certified by the American Board of Plastic Surgery?" This question matters because many providers perform cosmetic surgery without ABPS certification. The term "board certified" alone can be misleading—there exist organizations with official-sounding names that do not require the same training or examinations as ABPS [S1]. ASPS membership specifically requires ABPS certification, meaning a surgeon who is a member of the American Society of Plastic Surgeons has already met this foundational credential requirement [S1].
"What is your ABMS recognition status?" ABPS certification indicates that a surgeon has completed at least 6 years of surgical training including 3 years of plastic surgery residency, graduated from an accredited medical school, passed comprehensive oral and written examinations, and maintains continuing medical education including patient safety requirements annually [S1]. Verifying ABMS recognition helps distinguish rigorous credentialing from less stringent alternatives.
ASPS Membership and Training Requirements
Understanding what ASPS membership indicates about your surgeon can guide your evaluation. ASPS membership requires all of the following: ABPS certification, completion of 6 years of surgical training with dedicated plastic surgery residency, graduation from an accredited medical school, passage of board examinations, ongoing CME completion including annual patient safety education, operation in accredited surgical facilities, and adherence to the ASPS Code of Ethics [S1].
When discussing training background, consider asking about the surgeon's residency program duration and focus, fellowship training in aesthetic or breast surgery if applicable, and how long they have been practicing plastic surgery specifically. These details help you understand the depth of their preparation for your procedure.
Experience and Specialization
Beyond credentials, surgical experience significantly influences outcomes. Professional guidelines recommend asking about your surgeon's annual procedure volume with breast augmentation specifically—not just cosmetic surgery generally [S4]. A surgeon who performs high volumes of breast augmentation procedures may develop refined techniques and recognize complications earlier than those with limited experience in this specific area.
Ask directly: "How many breast augmentation procedures do you perform annually?" and "What is your revision surgery rate?" [S4]. Complication and revision rates provide insight into outcomes, though individual results may vary based on anatomy, healing response, and other patient-specific factors. Surgeons should be able to discuss their historical data honestly without guaranteeing specific outcomes.
Requesting to review before-and-after photographs of patients with similar anatomy and goals can also help you assess the surgeon's aesthetic approach and results consistency [S4].
Facility Safety and Accreditation
Surgical Facility Standards
The safety of your surgical environment matters as much as surgeon credentials. ASPS members are required to operate in accredited facilities, which typically means accreditation from organizations such as AAAASF (American Association for Accreditation of Ambulatory Surgery Facilities), AAAHC (Accrediting Association for Ambulatory Health Care), or JCAHO (Joint Commission on Accreditation of Healthcare Organizations) [S1].
During your consultation, verify that the surgical facility holds current accreditation from one of these recognized bodies. Accreditation indicates that the facility meets standards for equipment, safety protocols, staffing, and emergency response capabilities. Additionally, state licensing or Medicare certification provides further verification of facility standards [S1].
Key questions to ask:
"Is your surgical facility accredited, and by which organization?" AAAASF, AAAHC, or JCAHO accreditation represents the standard benchmark for outpatient surgical facilities in the United States [S1].
"What emergency protocols are in place if complications arise?" Understanding the facility's response capabilities for medical emergencies helps you assess safety preparedness.
"What is the accreditation status of the anesthesiologist or anesthesia team?" Qualified anesthesia providers with appropriate credentials and credentials verification contribute to overall surgical safety.
Implant Options and FDA Requirements
The FDA Patient Decision Checklist
Federal regulations require that patients receive and review a decision checklist before breast implant surgery. This checklist must be read aloud by the physician and signed by the patient, confirming that the patient has received device labeling and had opportunity to ask questions [S2].
The FDA patient decision checklist covers several critical areas [S2]:
Boxed warnings that highlight significant risks
BIA-ALCL risk factors and symptoms—a rare but serious lymphoma associated with certain textured implants
Systemic symptoms sometimes referred to as breast implant illness (BII)
Rupture screening recommendations for silicone implants
Implant registration requirements and processes
All four major manufacturers—Sientra, Ideal, Natrelle/Allergan, and Mentor—have adopted these checklists as required by FDA mandate [S3]. When you consult with a surgeon, confirming that the checklist will be completed and that you understand its contents represents a minimum standard for informed consent [S3].
Understanding Risks and Long-Term Care
For patients choosing silicone implants, the FDA recommends MRI screening beginning 5-6 years after implantation and repeating every 2-3 years thereafter to detect silent ruptures [S2]. Unlike saline ruptures which are immediately apparent, silicone ruptures may occur without obvious symptoms, making surveillance imaging an important consideration for long-term implant management.
Questions to include in your discussion:
"What implant type do you recommend for my anatomy and goals, and why?" Understanding the surgeon's reasoning helps you evaluate their approach to personalized recommendations.
"What are the specific surveillance recommendations for the implants you use?" This question addresses the FDA MRI screening timeline and any additional monitoring the surgeon recommends [S2].
"What implant warranties are available, and what do they cover?" Understanding warranty coverage helps you plan for potential future considerations.
"How do you handle revision surgery if complications arise?" Knowing the surgeon's approach to managing complications provides insight into long-term care commitment.
FDA Checklist Represents Minimum Standards
The federally mandated patient decision checklist establishes baseline disclosure requirements, but patients should seek information beyond these minimums. The checklist ensures that benefits AND risks are reviewed, but thorough understanding requires active engagement and follow-up questions [S3].
Red Flags and Documentation
Warning Signs During Consultation
Certain patterns during a consultation may indicate concerns worth heeding. The ASPS Code of Ethics and professional standards suggest watching for these red flags [S1]:
Guaranteed outcomes or "zero risk" language—ethical surgeons discuss realistic expectations rather than promising specific results
Pressure to decide immediately—legitimate consultations allow time for reflection and do not rush decision-making
Reluctance to provide complication statistics or revision rates—transparent surgeons discuss outcomes honestly
Inability or unwillingness to show before-and-after photographs—photo review represents standard practice
No clear process for follow-up care coordination—especially important for international patients planning travel
Documentation to Request
After your consultation, requesting specific materials helps establish your records and ensures you have received complete information:
Signed copy of the FDA patient decision checklist [S2]
Implant manufacturer information and device cards for registration
Written summary of your surgical plan including implant specifications
Surgeon's credentials verification (you may independently verify through ABMS or ASPS directories)
Facility accreditation documentation
Complication and revision rate information if provided during consultation
Contact protocols for post-operative questions and concerns
This documentation creates a reference point for your decision and establishes clear communication channels for your care journey.
Action Checklist for Your Consultation
Use this checklist when preparing for and attending your breast augmentation consultation:
Before the consultation:
[ ] Research ABPS certification and ABMS recognition
[ ] Verify the surgeon's ASPS membership status through independent means
[ ] Review the facility accreditation status
[ ] Prepare your list of questions based on this guide
During the consultation:
[ ] Confirm ABPS certification specifically
[ ] Request to see the FDA patient decision checklist [S2]
[ ] Ask about annual breast augmentation volume and revision rates [S4]
[ ] Verify facility accreditation [S1]
[ ] Discuss implant options and surveillance recommendations [S2]
[ ] Request before-and-after photo review [S4]
[ ] Clarify the process for post-operative care, especially as an international patient
After the consultation:
[ ] Obtain a signed copy of the FDA checklist
[ ] Receive written materials on implants and surgical plan
[ ] Confirm follow-up appointment scheduling
[ ] Document any unanswered questions for follow-up
[ ] Verify your understanding of the recovery timeline and restrictions
For patients traveling to Istanbul, additional considerations include discussing follow-up care coordination after returning home, understanding the process for addressing any complications that may arise after departure, and verifying that the surgeon's credentials meet both local Turkish Medical Association standards and align with the international benchmarks discussed in this guide.